Antibody treatment may be an effective and rapid way to battle coronavirus outbreaks in high-risk communities such as nursing homes

Pharmaceutical company Eli Lilly has announced its experimental antibody treatment can reduce a person’s risk of contracting COVID-19 by up to 80 percent. These preliminary results, from an ongoing Phase 3 trial, suggest the treatment may be an effective way to rapidly tamp down coronavirus outbreaks in unvaccinated communities.

Continue Reading

Category: Health & Wellbeing, Lifestyle

Tags: , , , ,